HomeMedia  /  News Release

2011

- Oroxcell is accredited by AFSSAPS (French Authorities) Level A, for performing regulatory toxicity studies for both Pharma and Cosmetic industries.

2009

- March, 9th to 10th: Oroxcell has presented a poster, VALIDATION OF THE RECONSTRUCTED HUMAN EPIDERMIS (RHE) SKIN IRRITATION ASSAY FOR FULL REPLACEMENT OF THE DRAIZE TEST

2008

- November, 4th to 5th: ESAC, which is the scientific committee of ECVAM, reports that the results obtained in the studies made by L’Oréal, Lancaster Cotty and Oroxcell, concerning the RHE® validation by SkinEthic, is able to completely substitute the Draize test in irritation evaluation of chemicals on the skin

- Oroxcell’s project concerning the pain program has been accreditated by the Biocluster Medicen Paris Region and financed by the French Ministry of Industry

- July: Receipt of £680 000 of financial support from Paris Ile de France and Seine-Saint-Denis department

2007

- Signature of a total agency contract for Japan market with Japanese’s Nosan Corporation in the medical product absorption field

- Signature of an agreement with Mutabilis

1 | 2